Sage Therapeutics, Inc. Business Finance Contracts & Agreements
17 Contracts & Agreements
- Exchange Agreements (4 contracts)
- Investor Rights Agreements (1)
- Stock Agreements (5)
- Underwriting Agreements (7)
- 2014 Employee Stock Purchase Plan, as amended (Filed With SEC on August 7, 2023)
- 2014 Employee Stock Purchase Plan, as amended (Filed With SEC on August 2, 2022)
- Underwriting Agreement, dated as of February 25, 2019, by and among Sage Therapeutics, Inc. and Goldman Sachs & Co. LLC. and J.P. Morgan Securities LLC (Filed With SEC on February 27, 2019)
- Underwriting Agreement, dated as of February 8, 2018, among Sage Therapeutics, Inc. and J.P. Morgan Securities LLC, Goldman, Sachs & Co. LLC and Morgan Stanley & Co. LLC, as... (Filed With SEC on February 9, 2018)
- Underwriting Agreement, dated as of November 14, 2017, among Sage Therapeutics, Inc. and J.P. Morgan Securities LLC, Goldman, Sachs & Co. LLC and Morgan Stanley & Co. LLC, as... (Filed With SEC on November 15, 2017)
- 2014 Employee Stock Purchase Plan (Filed With SEC on August 3, 2017)
- SAGETHERAPEUTICS, INC. 4,402,515 Shares of Common Stock Underwriting Agreement (thisAgreement) (Filed With SEC on September 9, 2016)
- SAGETHERAPEUTICS, INC. 3,157,894 Shares of Common Stock Underwriting Agreement (thisAgreement) (Filed With SEC on January 7, 2016)
- SAGE THERAPEUTICS, INC. [] Shares of Common Stock Underwriting Agreement (this Agreement) (Filed With SEC on April 13, 2015)
- SAGE THERAPEUTICS, INC. 2014 EMPLOYEE STOCK PURCHASE PLAN (Filed With SEC on July 8, 2014)
- ***Text Omitted and Filed Separately with the Securities and Exchange Commission Confidential Treatment Requested Under 17 C.F.R. Sections200.80(b)(4) and 230.406 SUPPLY AGREEMENT (Filed With SEC on July 8, 2014)
- ***Text Omitted and Filed Separately with the Securities and Exchange Commission Confidential Treatment Requested Under 17 C.F.R. Sections200.80(b)(4) and 230.406 Non-Exclusive... (Filed With SEC on July 8, 2014)
- ***Text Omitted and Filed Separately with the Securities and Exchange Commission Confidential Treatment Requested Under 17 C.F.R. Sections200.80(b)(4) and 230.406 COMMERCIAL... (Filed With SEC on July 8, 2014)
- ***Text Omitted and Filed Separately with the Securities and Exchange Commission Confidential Treatment Requested Under 17 C.F.R. Sections200.80(b)(4) and 230.406 EXCLUSIVE... (Filed With SEC on July 8, 2014)
- SAGE THERAPEUTICS, INC. 2011 STOCK OPTION AND GRANT PLAN (Filed With SEC on July 8, 2014)
- SECOND AMENDED AND RESTATED INVESTORS RIGHTS AGREEMENT (Filed With SEC on July 8, 2014)
- SAGE THERAPEUTICS, INC. [] Shares of Common Stock Underwriting Agreement (this Agreement) (Filed With SEC on July 8, 2014)
